000 01278 a2200373 4500
005 20250518033559.0
264 0 _c20190916
008 201909s 0 0 ger d
022 _a1613-7671
024 7 _a10.1007/s00508-019-1455-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrath, Helmut
245 0 0 _a[Smoking, alcohol and diabetes (Update 2019)].
_h[electronic resource]
260 _bWiener klinische Wochenschrift
_cMay 2019
300 _a67-70 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlcohol Drinking
_xadverse effects
650 0 4 _aBenzazepines
_xtherapeutic use
650 0 4 _aBupropion
_xtherapeutic use
650 0 4 _aDiabetes Mellitus
650 0 4 _aHumans
650 0 4 _aNicotine
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aQuinoxalines
650 0 4 _aSmoking
_xadverse effects
650 0 4 _aSmoking Cessation
_xmethods
650 0 4 _aTobacco Use Cessation Devices
650 0 4 _aVarenicline
_xtherapeutic use
700 1 _aKaser, Susanne
700 1 _aTatschl, Christian
700 1 _aFasching, Peter
773 0 _tWiener klinische Wochenschrift
_gvol. 131
_gno. Suppl 1
_gp. 67-70
856 4 0 _uhttps://doi.org/10.1007/s00508-019-1455-z
_zAvailable from publisher's website
999 _c29583852
_d29583852